Literature DB >> 15301734

Polymorphism of Prodynorphin promoter is associated with schizophrenia in Chinese population.

Chang-Shun Zhang1, Zheng Tan, Lan Lu, Sheng-Nan Wu, Ying He, Niu-Fan Gu, Guo-Yin Feng, Lin He.   

Abstract

AIM: To investigate the correlation between single nucleotide polymorphisms (SNPs) of functional candidate gene Prodynorphin (PDYN) and schizophrenia.
METHODS: SNPs in the promoter and exon regions of PDYN were screened and genotyped for association study in a cohort of Chinese Han schizophrenia cases and controls.
RESULTS: Two SNPs PDYN-1576C>T and PDYN-946C>G were identified in the promoter region but PDYN-946C>G showed significant differences of allele distribution (x2=6.15, P=0.013) and genotype distribution (x2=6.87, P=0.032) between schizophrenic and control subjects.
CONCLUSION: PDYN-946C>G polymorphism demonstrated an association with population susceptibility to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15301734

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  6 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

2.  Pain sensitivity is altered in animals after subchronic ketamine treatment.

Authors:  Axel Becker; Gisela Grecksch; Helmut Schröder
Journal:  Psychopharmacology (Berl)       Date:  2006-10-03       Impact factor: 4.530

3.  Correlation between metabolic enzyme GSTP1 polymorphisms and susceptibility to lung cancer.

Authors:  Yufei Wang; B U Ren; Lei Zhang; Zhanlin Guo
Journal:  Exp Ther Med       Date:  2015-07-30       Impact factor: 2.447

4.  Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia.

Authors:  Axel Becker; Gisela Grecksch; Gerald Zernig; Elisabeth Ladstaetter; Christoph Hiemke; Ulrich Schmitt
Journal:  Psychopharmacology (Berl)       Date:  2008-09-23       Impact factor: 4.530

Review 5.  The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective.

Authors:  Sonia Podvin; Tony Yaksh; Vivian Hook
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

Review 6.  Epigenetic and Transcriptional Control of the Opioid Prodynorphine Gene: In-Depth Analysis in the Human Brain.

Authors:  Olga Nosova; Igor Bazov; Victor Karpyak; Mathias Hallberg; Georgy Bakalkin
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.